138 related articles for article (PubMed ID: 17179443)
1. DNA (cytosine-5) methyltransferase inhibitors: a potential therapeutic agent for schizophrenia.
Levenson JM
Mol Pharmacol; 2007 Mar; 71(3):635-7. PubMed ID: 17179443
[TBL] [Abstract][Full Text] [Related]
2. DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes.
Kundakovic M; Chen Y; Costa E; Grayson DR
Mol Pharmacol; 2007 Mar; 71(3):644-53. PubMed ID: 17065238
[TBL] [Abstract][Full Text] [Related]
3. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia.
Dong E; Agis-Balboa RC; Simonini MV; Grayson DR; Costa E; Guidotti A
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12578-83. PubMed ID: 16113080
[TBL] [Abstract][Full Text] [Related]
4. The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes.
Kundakovic M; Chen Y; Guidotti A; Grayson DR
Mol Pharmacol; 2009 Feb; 75(2):342-54. PubMed ID: 19029285
[TBL] [Abstract][Full Text] [Related]
5. The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia.
Grayson DR; Chen Y; Costa E; Dong E; Guidotti A; Kundakovic M; Sharma RP
Pharmacol Ther; 2006 Jul; 111(1):272-86. PubMed ID: 16574235
[TBL] [Abstract][Full Text] [Related]
6. DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures.
Noh JS; Sharma RP; Veldic M; Salvacion AA; Jia X; Chen Y; Costa E; Guidotti A; Grayson DR
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1749-54. PubMed ID: 15671176
[TBL] [Abstract][Full Text] [Related]
7. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters.
Dong E; Guidotti A; Grayson DR; Costa E
Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4676-81. PubMed ID: 17360583
[TBL] [Abstract][Full Text] [Related]
8. DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients.
Dong E; Ruzicka WB; Grayson DR; Guidotti A
Schizophr Res; 2015 Sep; 167(1-3):35-41. PubMed ID: 25476119
[TBL] [Abstract][Full Text] [Related]
9. DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains.
Veldic M; Caruncho HJ; Liu WS; Davis J; Satta R; Grayson DR; Guidotti A; Costa E
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):348-53. PubMed ID: 14684836
[TBL] [Abstract][Full Text] [Related]
10. S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis.
Guidotti A; Ruzicka W; Grayson DR; Veldic M; Pinna G; Davis JM; Costa E
Neuroreport; 2007 Jan; 18(1):57-60. PubMed ID: 17259861
[TBL] [Abstract][Full Text] [Related]
11. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability.
Tremolizzo L; Carboni G; Ruzicka WB; Mitchell CP; Sugaya I; Tueting P; Sharma R; Grayson DR; Costa E; Guidotti A
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17095-100. PubMed ID: 12481028
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice.
Matrisciano F; Tueting P; Dalal I; Kadriu B; Grayson DR; Davis JM; Nicoletti F; Guidotti A
Neuropharmacology; 2013 May; 68():184-94. PubMed ID: 22564440
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic subtypes can be characterized by differences in their ability to modify GABAergic promoter methylation.
Dong E; Grayson DR; Guidotti A; Costa E
Epigenomics; 2009 Oct; 1(1):201-11. PubMed ID: 22122643
[TBL] [Abstract][Full Text] [Related]
14. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1.
Veldic M; Guidotti A; Maloku E; Davis JM; Costa E
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2152-7. PubMed ID: 15684088
[TBL] [Abstract][Full Text] [Related]
15. Reelin promoter hypermethylation in schizophrenia.
Grayson DR; Jia X; Chen Y; Sharma RP; Mitchell CP; Guidotti A; Costa E
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9341-6. PubMed ID: 15961543
[TBL] [Abstract][Full Text] [Related]
16. [Epigenetic model in the pharmacologic modulation of vulnerability to schizophrenia].
Tremolizzo L
Encephale; 2007 Nov; 33(Pt 3):867-9. PubMed ID: 18402359
[No Abstract] [Full Text] [Related]
17. Association study of the reelin (RELN) gene with Chinese Va schizophrenia.
Yang XB; Kang C; Liu H; Yang J
Psychiatr Genet; 2013 Jun; 23(3):138. PubMed ID: 23277132
[No Abstract] [Full Text] [Related]
18. GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability.
Costa E; Grayson DR; Mitchell CP; Tremolizzo L; Veldic M; Guidotti A
Crit Rev Neurobiol; 2003; 15(2):121-42. PubMed ID: 14977367
[TBL] [Abstract][Full Text] [Related]
19. GABAergic dysfunction in mGlu7 receptor-deficient mice as reflected by decreased levels of glutamic acid decarboxylase 65 and 67kDa and increased reelin proteins in the hippocampus.
Wierońska JM; Brański P; Siwek A; Dybala M; Nowak G; Pilc A
Brain Res; 2010 Jun; 1334():12-24. PubMed ID: 20353761
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of RELN and GAD1 in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects.
Zhubi A; Chen Y; Guidotti A; Grayson DR
Int J Dev Neurosci; 2017 Nov; 62():63-72. PubMed ID: 28229923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
